To explore the effect of the interaction between KDM2A and c-Fos in cancer cells after TPA treatment, KDM2A expression was down-regulated by KDM2A siRNA (Figure 6A) to test the binding activity of c-Fos to the COX-2 promoter. Here, FOS is linked to cancer.